BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33140823)

  • 1. Kaposi Sarcoma Rates Among Persons Living With Human Immunodeficiency Virus in the United States: 2008-2016.
    Luo Q; Satcher Johnson A; Hall HI; Cahoon EK; Shiels M
    Clin Infect Dis; 2021 Oct; 73(7):e2226-e2233. PubMed ID: 33140823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.
    White DL; Oluyomi A; Royse K; Dong Y; Nguyen H; Chang E; Richardson P; Jiao L; Garcia JM; Kramer JR; Thrift AP; Chiao E
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):387-394. PubMed ID: 31242141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Trends of Kaposi Sarcoma Among Young Non-Hispanic Black Men by US Regions, 2001-2018.
    Suk R; White DL; Knights S; Nijhawan A; Deshmukh AA; Chiao EY
    JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36352501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States.
    Mahale P; Engels EA; Coghill AE; Kahn AR; Shiels MS
    Clin Infect Dis; 2018 Jun; 67(1):50-57. PubMed ID: 29325033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in incidence & survival of Kaposi's sarcoma in the United States.
    Kumar V; Soni P; Garg M; Hashmi AT; Chandra AB
    Indian J Med Res; 2019 Mar; 149(3):354-363. PubMed ID: 31249200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013.
    Royse KE; El Chaer F; Amirian ES; Hartman C; Krown SE; Uldrick TS; Lee JY; Shepard Z; Chiao EY
    PLoS One; 2017; 12(8):e0182750. PubMed ID: 28829790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
    Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
    Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015.
    Peprah S; Engels EA; Horner MJ; Monterosso A; Hall HI; Johnson AS; Pfeiffer RM; Shiels MS
    Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1627-1633. PubMed ID: 34162660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001-2015.
    Zhang ER; Pfeiffer RM; Austin A; Clarke MA; Hayes J; Horner MJ; Monterosso A; Pawlish KS; Engels EA; Shiels MS
    J Natl Cancer Inst; 2022 Sep; 114(9):1246-1252. PubMed ID: 35575389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?
    Chaabna K; Bray F; Wabinga HR; Chokunonga E; Borok M; Vanhems P; Forman D; Soerjomataram I
    Int J Cancer; 2013 Sep; 133(5):1197-203. PubMed ID: 23436712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men.
    Luu HN; Amirian ES; Chiao EY; Scheurer ME
    Cancer Med; 2014 Dec; 3(6):1635-43. PubMed ID: 25139791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
    Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA
    JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer burden in the HIV-infected population in the United States.
    Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
    J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review.
    Chang E; Mapakshi SR; Mbang P; El-Mallawany NK; Kramer JR; White DL; Chiao EY
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):141-148. PubMed ID: 29985803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
    Moorad R; Kasonkanji E; Gumulira J; Gondwe Y; Dewey M; Pan Y; Peng A; Pluta LJ; Kudowa E; Nyasosela R; Tomoka T; Tweya H; Heller T; Gugsa S; Phiri S; Moore DT; Damania B; Painschab M; Hosseinipour MC; Dittmer DP
    Int J Cancer; 2023 Dec; 153(12):2082-2092. PubMed ID: 37602960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.
    Haas CB; Engels EA; Horner MJ; Freedman ND; Luo Q; Gershman S; Qiao B; Pfeiffer RM; Shiels MS
    Lancet HIV; 2022 Oct; 9(10):e700-e708. PubMed ID: 36179753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005.
    Armstrong AW; Lam KH; Chase EP
    Epidemiol Infect; 2013 Jan; 141(1):200-6. PubMed ID: 22404880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.
    Akanbi MO; Bilaver LA; Achenbach C; Hirschhorn LR; Rivera AS; Adekolujo OS; Adekola KUA; Silas OA; Agaba PA; Agbaji O; Shehu NY; Sagay SA; Hou L; Murphy RL
    BMC Cancer; 2023 Sep; 23(1):890. PubMed ID: 37735371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
    Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
    HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.